Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinical Hospital NEUROVITA is a specialized medical and research center based in Moscow, Russia, focusing on restorative interventional neurology and oncology. The clinic is renowned for its pioneering work in cell-based therapies, particularly the use of autologous stem cells and dendritic cell vaccines to treat severe neurological conditions and solid tumors. Led by Professor Andrey Bryukhovetskiy, NEUROVITA integrates advanced biotechnological research with clinical practice, offering treatments for spinal cord injuries, stroke, and malignant brain tumors. The facility operates its own specialized laboratory for the processing and cultivation of various cell types, including hematopoietic and neural stem cells, providing personalized regenerative medicine solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinical Hospital NEUROVITA.